Download the full list of Medical Research Future Fund (MRFF) grant recipients.

MRFF grants with payments in 2020-21

Type of grant

Grants

Value ($m)

Competitive

503

486.5

Competitive pre-qualified

13

53.5

Percentage - Competitive

95%

90%

Targeted: Clinical leadership

5

8.8

Targeted: National expansion / co-contribution

8

20.8

Targeted: Patient led

14

28.3

Percentage - Targeted

5%

10%

Total MRFF Grants

543

597.9

These are the MRFF grant agreements that were active and also had a payment made in that financial year. The value reflects the payments made in the financial year, rather than the total value of the grant agreement.

Since inception of the MRFF in 2015, all grants announced, committed or paid as at 30 June 2021

Type of grant

Grants

Value ($m)

Competitive

583

1,280.9

Competitive pre-qualified

34

144.9

Percentage - Competitive

92%

80%

Targeted: Clinical leadership

10

59.3

Targeted: National expansion / co-contribution

17

151.0

Targeted: Patient led

26

143.9

Percentage - Targeted

8%

20%

Total MRFF Grants

670

1,779.8

This table includes all MRFF grants awarded and announced since the program’s inception in 2015 and the total value of the grant agreement across all financial years.

Category Description

Competitive

Funding allocated through an openly advertised MRFF opportunity and through which applicants are independently assessed against published assessment criteria. 

Competitive pre‑qualified

Funding allocated to a specific organisation following their selection in an open competitive application process outside the MRFF.  Examples include Advanced Health Research and Translation Centres (assessed by NHMRC), ARC Special Research Initiative, or Industry Growth Centre (assessed by the Department of Industry, Innovation and Science).

Targeted

Funding is awarded to a specific applicant following assessment of their application against predefined criteria.  The following subcategories may apply:

Clinical leadership

Funding allocated to an organisation that is nationally recognised for its role in clinical leadership and/or quality standards, including through health and medical research, in Australia.

National Expansion / co‑contribution

Funding allocated to a project operating at a local or state level, where expansion would provide equity of access or that leverages non-MRFF funds to expand the research activity.

Patient led

Funding allocated to an organisation driving a patient-led agenda for health and medical research and health service delivery (e.g., through a foundation).

Last updated: 
30 August 2021